GAN Limited
GAN
$1.78
$0.010.57%
Weiss Ratings | GAN - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Rating | ||||
Reward Index | Very Weak | |||
Risk Index | Weak | |||
Risk Grade | D | |||
Reward Grade | E | |||
Rating Factors | GAN - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Dividend Index | -- | |||
Growth Index | Good | |||
Efficiency Index | Very Weak | |||
Solvency Index | Fair | |||
Total Return Index | Weak | |||
Volatility Index | Weak | |||
Beta / Standard Deviation | GAN - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Beta | 1.09 | |||
Price History | GAN - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
7-Day Total Return | 1.14% | |||
30-Day Total Return | -5.82% | |||
60-Day Total Return | -3.26% | |||
90-Day Total Return | -1.11% | |||
Year to Date Total Return | -2.73% | |||
1-Year Total Return | 26.24% | |||
2-Year Total Return | 27.14% | |||
3-Year Total Return | -61.64% | |||
5-Year Total Return | -- | |||
52-Week High % Change | -6.84% | |||
52-Week Low % Change | 51.28% | |||
Price | GAN - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
52-Week High Price | $1.90 | |||
52-Week Low Price | $1.17 | |||
52-Week Low Price (Date) | Apr 29, 2024 | |||
52-Week High Price (Date) | Jan 29, 2025 | |||
Valuation | GAN - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Market Cap | 80.66M | |||
Enterprise Value | 93.81M | |||
Price/Earnings (TTM) | -- | |||
Earnings Per Share (TTM) | -0.30 | |||
Earnings Per Share Growth | -92.58% | |||
Price/Earnings To Growth | -- | |||
Price/Sales (TTM) | 0.65 | |||
Price/Book (Q) | -14.00 | |||
Enterprise Value/Revenue (TTM) | 0.70 | |||
Price | $1.78 | |||
Enterprise Value/EBITDA (TTM) | -47.40 | |||
Enterprise Value/EBIT | -9.85 | |||
Market Cap Category | Micro Cap | |||
Dividends and Shares | GAN - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Shares Outstanding | 48.89M | |||
Dividend Yield | -- | |||
Div. Per Share (Most Recent) | -- | |||
Dividend Per Share (TTM) | -- | |||
Payout Ratio (TTM) | -- | |||
Dividend Per Share (Most Recent) | -- | |||
Company Info | GAN - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Phone Number | 833 565 0550 | |||
Address | 400 Spectrum Center Drive Irvine, CA 92618 | |||
Website | www.gan.com | |||
Country | United States | |||
Year Founded | 1999 | |||
Profitability | GAN - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Operating Margin (TTM) | -7.10% | |||
Profit Margin | -9.83% | |||
Management Effectiveness | GAN - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Return on Assets | -6.95% | |||
Return on Equity | -- | |||
Income Statement | GAN - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Revenue (TTM) | 134.02M | |||
Total Revenue (TTM) | 134.02M | |||
Revenue Per Share | $2.74 | |||
Gross Profit (TTM) | 94.73M | |||
EBITDA (TTM) | -1.98M | |||
EBIT (TTM) | -9.52M | |||
Net Income (TTM) | -13.18M | |||
Net Income Avl. to Common (TTM) | -13.18M | |||
Total Revenue Growth (Q YOY) | 24.42% | |||
Earnings Growth (Q YOY) | 125.53% | |||
EPS Diluted (TTM) | -0.30 | |||
EPS Diluted Growth (Q YOY) | 121.91% | |||
Balance Sheet | GAN - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Cash and Short-Term Inv. (Q) | 36.48M | |||
Cash Per Share (Q) | $0.75 | |||
Total Current Assets (Q) | 55.48M | |||
Total Preferred Equity (Q) | -- | |||
Total Equity (Q) | -5.75M | |||
Current Ratio (Q) | 1.740 | |||
Book Value Per Share (Q) | -$0.13 | |||
Total Assets (Q) | 82.63M | |||
Total Current Liabilities (Q) | 31.88M | |||
Total Debt (Q) | 49.63M | |||
Total Liabilities (Q) | 88.38M | |||
Total Common Equity (Q) | -5.75M | |||
Cash Flow | GAN - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Cash from Investing (TTM) | -4.29M | |||
Cash from Financing (TTM) | 97.00K | |||
Net Change in Cash (TTM) | -2.73M | |||
Levered Free Cash Flow (TTM) | -180.20K | |||
Cash from Operations (TTM) | 213.00K | |||